2021 tables: Institutions - Nature & Science - corporate

The 2021 tables are based on Nature Index data from 1 January 2020 to 31 December 2020.

Table criteria

# Institution Share 2019 Share 2020 Count 2020 Change in Adjusted Share 2019-2020*
1 Alphabet Inc., United States of America (USA) 3.83 6.23 10 47.6%
2 F. Hoffmann-La Roche AG, Switzerland 5.27 5.56 12 -4.4%
3 Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.12 3.12 6 2,279.3%
4 Merck & Co., Inc., United States of America (USA) 1.94 2.59 7 21.0%
5 BioNTech AG, Germany 2.10 4 N/A
6 Samsung Group, South Korea 0.81 2.06 7 129.5%
7 Novartis International AG, Switzerland 2.93 2.00 8 -38.1%
8 Vir Biotechnology, Inc., United States of America (USA) 0.01 1.89 3 12,225.6%
9 Pfizer Inc., United States of America (USA) 0.60 1.24 8 88.6%
10 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 0.74 1.21 7 48.4%
11 Bioqual, Inc., United States of America (USA) 0.09 1.18 5 1,119.3%
12 AbbVie Inc., United States of America (USA) 0.20 1.11 4 401.9%
13 Gilead Sciences, Inc., United States of America (USA) 0.06 1.10 3 1,595.0%
14 Amgen Inc., United States of America (USA) 1.69 1.04 6 -44.1%
15 Universal Display Corporation, United States of America (USA) 1.00 1 N/A
16 Johnson & Johnson, United States of America (USA) 0.86 0.80 7 -15.2%
17 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 0.14 0.79 4 403.7%
18 IBM Corporation, United States of America (USA) 4.73 0.79 3 -84.8%
19 Xerox Corporation, United States of America (USA) 0.02 0.75 1 4,192.0%
20 BGI, China 0.46 0.67 5 32.3%
21 Genomics England Ltd., United Kingdom (UK) 0.05 0.66 4 1,063.9%
22 Neoleukin Therapeutics, Inc., United States of America (USA) 0.66 1 N/A
23 Thermo Fisher Scientific Inc., United States of America (USA) 0.34 0.65 4 77.0%
24 Microsoft Corporation, United States of America (USA) 0.51 0.65 3 14.7%
25 Illumina, Inc., United States of America (USA) 0.30 0.65 7 98.0%
26 Xolo GmbH, Germany 0.60 1 N/A
27 Innate Pharma S.A., France 0.03 0.56 1 1,407.3%
28 Murata Manufacturing Co., Ltd., Japan 0.25 0.50 2 81.4%
29 Sinovac Biotech Co., Ltd., China 0.44 1 N/A
30 Lead Discovery Center GmbH (LDC), Germany 0.43 1 N/A
31 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 0.43 3 N/A
32 Adimab LLC, United States of America (USA) 0.40 2 N/A
33 AstraZeneca plc, United Kingdom (UK) 0.50 0.38 5 -32.1%
34 Thales S.A., France 0.09 0.36 2 251.2%
35 China National Chemical Corporation (ChemChina), China 0.11 0.35 2 188.7%
36 Novavax, Inc., United States of America (USA) 0.33 1 N/A
36 ideas42, United States of America (USA) 0.33 1 N/A
36 HP Inc., United States of America (USA) 0.33 1 N/A
37 Taiwan Semiconductor Manufacturing Company Limited (TSMC), Taiwan 0.32 1 N/A
38 Allchemy Inc., United States of America (USA) 0.31 1 N/A
39 Agios Pharmaceuticals, Inc., United States of America (USA) 0.30 1 N/A
40 Saudi Aramco, Saudi Arabia 0.30 1 N/A
41 SYSTEMIQ Ltd., United Kingdom (UK) 0.29 1 N/A
42 Moderna Therapeutics, Inc., United States of America (USA) 0.29 1 N/A
43 Raytheon Company, United States of America (USA) 0.28 2 N/A
44 Pantheon Biosciences Ltd., Israel 0.27 1 N/A
44 Royal Dutch Shell plc (Shell), Netherlands 0.27 1 N/A
45 Cell Signaling Technology, Inc., United States of America (USA) 0.27 2 N/A
46 Bayer AG, Germany 0.18 0.26 4 33.5%
47 Mission Bio, Inc., United States of America (USA) 0.25 1 N/A
48 China Shipbuilding Industry Corporation (CSIC), China 0.03 0.25 4 609.3%
49 Eli Lilly and Company, United States of America (USA) 0.02 0.24 3 1,085.6%
50 Bristol-Myers Squibb (BMS), United States of America (USA) 0.98 0.24 3 -77.6%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.